Catecholamine Refractory Vasodilatory Shock: Can Therapy Become Patient Specific?

J Cardiothorac Vasc Anesth. 2020 Jul;34(7):1994-1995. doi: 10.1053/j.jvca.2020.02.014. Epub 2020 Feb 12.

Authors

Jamel P Ortoleva¹, Amy L French², Adam A Dalia³

Affiliations

¹ Tufts Medical Center, Tufts University School of Medicine, Boston, MA.
² Department of Cardiology, Rhode Island Hospital, East Providence, RI.
³ Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston, MA; Department of Anesthesia, Critical Care, and Pain Medicine, Harvard Medical School, Boston, MA.

PMID: 32151509
DOI: 10.1053/j.jvca.2020.02.014

No abstract available

Publication types

Letter

MeSH terms

Catecholamines*
Humans
Shock* / drug therapy
Vasoconstrictor Agents / therapeutic use
Vasodilation

Substances

Catecholamines
Vasoconstrictor Agents